- Home
- EMKR vs LGVN Comparison
EMKR vs LGVN Comparison
Compare EMKR & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EMKR
- LGVN
- Stock Information
- Founded
- EMKR 1984
- LGVN 2014
- Country
- EMKR United States
- LGVN United States
- Employees
- EMKR N/A
- LGVN N/A
- Industry
- EMKR Semiconductors
- LGVN Medicinal Chemicals and Botanical Products
- Sector
- EMKR Technology
- LGVN Health Care
- Exchange
- EMKR Nasdaq
- LGVN Nasdaq
- Market Cap
- EMKR 9.5M
- LGVN 25.9M
- IPO Year
- EMKR 1997
- LGVN 2021
- Fundamental
- Price
- EMKR $2.33
- LGVN $2.09
- Analyst Decision
- EMKR Buy
- LGVN Strong Buy
- Analyst Count
- EMKR 2
- LGVN 2
- Target Price
- EMKR $3.00
- LGVN $8.00
- AVG Volume (30 Days)
- EMKR 2.0M
- LGVN 393.6K
- Earning Date
- EMKR 12-10-2024
- LGVN 11-08-2024
- Dividend Yield
- EMKR N/A
- LGVN N/A
- EPS Growth
- EMKR N/A
- LGVN N/A
- EPS
- EMKR N/A
- LGVN N/A
- Revenue
- EMKR $90,961,000.00
- LGVN $1,229,000.00
- Revenue This Year
- EMKR N/A
- LGVN $161.78
- Revenue Next Year
- EMKR $7.07
- LGVN $8.62
- P/E Ratio
- EMKR N/A
- LGVN N/A
- Revenue Growth
- EMKR 413.79
- LGVN 39.34
- 52 Week Low
- EMKR $0.78
- LGVN $0.77
- 52 Week High
- EMKR $7.20
- LGVN $23.90
- Technical
- Relative Strength Index (RSI)
- EMKR 67.47
- LGVN 54.70
- Support Level
- EMKR $2.07
- LGVN $1.76
- Resistance Level
- EMKR $2.54
- LGVN $2.26
- Average True Range (ATR)
- EMKR 0.16
- LGVN 0.12
- MACD
- EMKR -0.02
- LGVN 0.05
- Stochastic Oscillator
- EMKR 55.32
- LGVN 66.00
About EMKR EMCORE Corporation
EMCORE Corp is a provider of sensors and navigation systems for the aerospace and defense market. The company operates in one reporting segment, Inertial Navigation, whose product technology categories include: (a) FOG, (b) QMEMS, (c) RLG, in each case which serve the aerospace and defense market. The company operates geographically in United States and Canada, which is the key revenue generator; Asia; Europe; and Other.
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.